Oral azathioprine for steroid refractory severe ulcerative colitis [4]

American Journal of Gastroenterology

Volumn 96, Issue 9 SUPPL., 2001, Pages 2797-2798

  Mantzaris, Gerassimos J ^a   Archavlis, Emmanuel ^a   Kourtessas, Demetrius ^a   Amberiadis, Pericles ^a   Triantafyllou, George ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MESALAZINE; PREDNISOLONE; STEROID;

CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; SIGMOIDOSCOPY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0034821556     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02706-X     Document Type: Letter

References (6)

1. Intravenous azathioprine in severe ulcerative colitis: A pilot study
2. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease
3. Treatment of Crohn's disease with 6-mercaptopurine: A long-term, randomized, double-blind study
4. Azathioprine combined with porednisolone or monotherapy with prednisone in active Crohn's disease
5. A controlled double blind study of azathioprine in the management of Crohn's disease
6. Intensive intravenous regimen for severe attacks of ulcerative colitis